Craft

Laboratorios Richmond

Stock Price

$1.7 K

2024-10-29

Market Capitalization

$133.2 B

2024-10-29

Revenue

$126.7 B

FY, 2025

Laboratorios Richmond Summary

Company Summary

Overview
Laboratorios Richmond is a company that manufactures pharmaceutical products. It offers oncology, oncohematology, anti-platelet, psychiatric, and hypnotic drugs and medicines for the treatment of HIV, HCV, and multiple sclerosis.
Type
Public
Status
Active
Founded
1935
HQ
Buenos Aires, AR | view all locations
Website
https://ir.richmondlab.com/
Sectors

Key People

  • Pablo García Santillán

    Pablo García Santillán, Executive VP & CEO

  • Arturo Berger

    Arturo Berger, Director of Operations

  • Pablo Da Pos

    Pablo Da Pos, Technical Director, Quality and Compliance Manager

  • Maximiliano Bergman

    Maximiliano Bergman, Medical Director

LocationsView all

3 locations detected

  • Buenos Aires, Cdad. Autónoma de Buenos Aires HQ

    Argentina

    Bouchard 680

  • Buenos Aires, Cdad. Autónoma de Buenos Aires

    Argentina

    Av. Elcano 4938

  • Fatima, Provincia de Buenos Aires

    Argentina

    Calle 3, 517

Laboratorios Richmond Financials

Summary Financials

Revenue (FY, 2025)
$126.7B
Gross profit (FY, 2025)
$80.4B
Net income (FY, 2025)
$2.1B
Cash (FY, 2025)
$10.8B
EBIT (FY, 2025)
$32.8B
Enterprise value
$348.1B

Footer menu